Main > ONCOLOGY (**) > Head & Neck>Squamous>C.>MET Or R > TREAT.: > USA. B. NivoluMAb

---

USA. B. NivoluMAb's subsections
(*) CA Approval Date: 2017. 05.17
(*) EU Approval Date: 2017. 04.28
2nd Line Therapy>Pt ChemoTherapy
Company
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 10
Patent>UpDate: 2020. 02.18.
TradeMark
TradeMark Web-Site
UpDate: 2017. 05.17.

USA. B. NivoluMAb's products
This section has no products